Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
AssigneeMerial Limited
InventorCharles Q Meng
Life of this patent
Estimating the term…
Abstract
This invention relates to compositions for combating parasites in animals, comprising 1-arylpyrazole compounds in combination with substituted imidazole compounds. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infestation in an animal comprising administering the compositions of the invention to an animal in need thereof.
Claims16
A veterinary formulation for treating or preventing a parasitic infestation in an animal comprising:
- (a) a 1-aryl-5-alkyl or 5-haloalkylpyrazole of formula (IA) or aveterinarily acceptable salt thereof,
- wherein:
- R2a is —S(O)mR11a;
- R3a is methyl, ethyl or C1-C4 haloalkyl;
- R4a is halogen;
- R6a is C1-C4 alkyl or haloalkyl;
- R13a is halogen;
- R11a is C1-C4 haloalkyl;
- and
- m is 0, 1 or 2;
- (b) a substituted imidazole compound of formula (II),
- wherein
- X1 is H, Cl, or CH3;
- X2 and X8 are H;
- X3 is H, F, —OCH3, Cl, I, —OCHF3 , —OCF3 , NH2 , CHCH2 , CHCHCH3, CCH, CCCH3, C2H5 or CH3;
- X4, X5, X6 and X7 are H or CH3;
- (c) a veterinarily acceptable carrier;
- and
- (d) optionally a crystallization inhibitor.
A veterinary formulation for treating or preventing a parasitic infestation in an animal comprising:
- (a) a 1-aryl-5-alkyl or 5-haloalkylpyrazole of formula (IB) or a veterinarily acceptable salt thereof,
- wherein:
- R1b is alkyl, CN or halogen;
- R2b is S(O)6R14b or 4,5-dicyanoimidazol-2-yl or haloalkyl;
- R14b is alkyl or haloalkyl;
- R3b is a hydrogen, halogen, —NR7bR8b, —S(O)mR9b, —C(O)R9b, —C(O)OR9b, alkyl, haloalkyl, —OR10b or an —N═C(R11b) (R12b);
- R6b is a halogen, haloalkyl, haloalkoxy, S(O)qCF3 or SF5 group;
- R7B and R8B independently represent a hydrogen, alkyl, haloalkyl, —C(O)alkyl, —S(O)rCF3, acyl or alkoxycarbonyl;
- or
- R7b and R8b can together form a divalent alkylene radical which is optionally interrupted by one or two divalent heteroatoms;
- R9b is an alkyl or haloalkyl;
- R10b is hydrogen, alkyl or haloalkyl;
- R11b is hydrogen or alkyl radical;
- R12b is an optionally substituted aryl or an optionally substituted heteroaryl group;
- R4b and R13b represent, independently of one another, hydrogen, halogen CN or NO2;
- m, n, q and r represent, independently of one another, an integer equal to 0, 1 or 2;
- and
- Z represents a trivalent nitrogen atom or a C—R13b radical, the three other valencies of the Carbon atom forming part of the aromatic ring;
- (b) a substituted imidazole compound of formula (II),
- wherein
- X1 is H, Cl, or CH3;
- X2 and X8 are H;
- X3 is H, F, —OCH3, Cl, I, —OCHF3 , —OCF3 , NH2 , CHCH2 , CHCHCH3, CCH, CCCH3, C2H5 or CH3;
- X4, X5, X6 and X7 are H or CH3;
- (c) a veterinarily acceptable carrier;
- and
- (d) optionally a crystallization inhibitor.
A composition for the treatment and prevention of a parasitic infestation in an animal comprising the 1-arylpyrazole compound fipronil, the substituted imidazole compound 1H-imidazole, 2-(2,3-dihydro-4-methyl-1H-inden-1-yl);
- at least one veterinarily acceptable carrier, and optionally a crystallization inhibitor.
Dependencies are inferred from the claim text.